Bobrov, E., Skobeleva, N., Restifo, D., Beglyarova, N., Cai, K. Q., Handorf, E., . . . Astsaturov, I. (2016). Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Oncotarget.
Παραπομπή Chicago StyleBobrov, Egor, et al. "Targeted Delivery of Chemotherapy Using HSP90 Inhibitor Drug Conjugates Is Highly Active against Pancreatic Cancer Models." Oncotarget 2016.
Παραπομπή MLABobrov, Egor, et al. "Targeted Delivery of Chemotherapy Using HSP90 Inhibitor Drug Conjugates Is Highly Active against Pancreatic Cancer Models." Oncotarget 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.